Roche Achieves CE IVDR Approval for Revolutionary HER2 Diagnostic Test in Cancer Treatment Roche has secured CE IVDR approval for the VENTANA HER2 (4B5) test, facilitating precise identification of breast and biliary tract cancers, incorporating personalized treatment options.

Roche Achieves CE IVDR Approval for Revolutionary HER2 Diagnostic Test in Cancer Treatment #USA #Cancer_Treatment #Tucson #Roche_Diagnostics #VENTANA_HER2